Harnessing the power of biomarker and drug analysis for clinical research and drug development.

Capabilities 

Pharmacokinetic analysis

  • Quantification of drug compound and metabolites
  • Structural elucidation of drug metabolite 

Biomarker quantification

  • Biomarker discovery- proteomics and metabolomics
  • Biomarker validation 

Mechanistic elucidation

  • Label-free proteomics
  • In vivo SILAC (Stable Isotope Labelling with Amino Acids in Cell Culture) analysis

Speciality

BMDA has built a portfolio of 3 analytical platforms and assays in the last few years for a wide range of clinical and preclinical appliactions.

Biomarker platform/assay Analytical validation Preclinicial validation Clinical application
 Desmosine
 Neurosteroids
_
 Pathway enhanced in vivo SILAC
_

 

Established in 2011, the Biomarker and Drug Analysis Laboratory (BMDA) provides analytical services for quantitative and qualitative analyses of soluble biomarkers, drug compounds and metabolites with state-of-the-art LC-MS/MS instruments to the researchers at the University of Dundee and to external academics and industrial clients. The laboratory is Good Clinical Laboratory compliant since 2016.



Address

Jacqui Wood Centre, James Arrott Drive
School of Medicine
Ninewells Hospital & Medical School
University of Dundee
Dundee
DD2 1UB
View facility on Campus Map

Enquiries

Dr Jeffrey Huang
j.t.j.huang@dundee.ac.uk
  +44 (0)1382 386901